Aurobindo Pharma Gets US FTC Approval for Lannett Acquisition

Aurobindo Pharma USA Inc., a subsidiary of Aurobindo Pharma Ltd, has received the necessary approval from the US Federal Trade Commission (FTC) to acquire Lannett Company LLC. This marks a significant step towards the completion of the acquisition, which is expected to close by the end of the current month. The company previously entered into a definitive agreement to acquire 100% of Lannett Company LLC from LANNETT SELLER HOLDCO, INC. Aurobindo Pharma will continue to keep the stock exchanges informed of any further developments.